An analysis of Pbx1 expression in ovarian tumor samples indicated that Pbx1 was upregulated in these samples, and the overexpression of Pbx1 led to platinum-based chemotherapy resistance in patients with ovarian cancer (Jung et al., 2016). This evidence concerns the gene PBX1 and ovarian neoplasm.